Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis

被引:405
作者
Rodig, N
Ryan, T
Allen, JA
Pang, H
Grabie, N
Chernova, T
Greenfield, EA
Liang, SC
Sharpe, AH
Lichtman, AH
Freeman, GJ
机构
[1] Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA
关键词
T lymphocytes; endothelial cells; costimulation;
D O I
10.1002/eji.200324270
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interactions between CD8(+) T cells and endothelial cells are important in both protective and pathologic immune responses. Endothelial cells regulate the recruitment of CD8(+) T cells into tissues, and the activation of CD8+ T cells by antigen presentation and costimulatory signals. PD-L1 and PD-L2 are recently described B7-family molecules which bind to PD-1 on activated lymphocytes and down-regulate T cell activation. We found that PD-L1 is expressed on interferon-gamma stimulated cultured human and mouse endothelial cells, while PD-L2 was found on stimulated human but not mouse endothelial cells. Expression was further upregulated by TNF-alpha. Antibody blockade of endothelial cell PD-L1 and PD-L2 enhanced endothelial cell costimulation of PHA-activated human CD8(+) T cells. Antibody blockade of mouse endothelial cell PD-L1 enhanced both IFN-gamma secretion and cytolytic activity of CD8(+) T cells in response to endothelial cell antigen presentation. These results show that IFN-gamma activated endothelial cells can inhibit T cell activation via expression of the immunoinhibitory PD-L1 and PD-L2 molecules. Endothelial expression of PD-ligands would allow activation and extravasation of T cells without excessive vessel damage. Our findings highlight a potentially important pathway by which endothelial cells down-regulate CD8(+) T cell-mediated immune responses.
引用
收藏
页码:3117 / 3126
页数:10
相关论文
共 42 条
[1]   Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: Attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses [J].
Bennett, F ;
Luxenberg, D ;
Ling, V ;
Wang, IM ;
Marquette, K ;
Lowe, D ;
Khan, N ;
Veldman, G ;
Jacobs, KA ;
Valge-Archer, VE ;
Collins, M ;
Carreno, BM .
JOURNAL OF IMMUNOLOGY, 2003, 170 (02) :711-718
[2]  
Biedermann BC, 1998, J IMMUNOL, V161, P4679
[3]  
Briscoe DM, 1997, KIDNEY INT, pS22
[4]  
Briscoe DM, 1997, J IMMUNOL, V159, P3247
[5]   Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production [J].
Brown, JA ;
Dorfman, DM ;
Ma, FR ;
Sullivan, EL ;
Munoz, O ;
Wood, CR ;
Greenfield, EA ;
Freeman, GJ .
JOURNAL OF IMMUNOLOGY, 2003, 170 (03) :1257-1266
[6]   INDUCTION OF OVALBUMIN-SPECIFIC CYTO-TOXIC T-CELLS BY INVIVO PEPTIDE IMMUNIZATION [J].
CARBONE, FR ;
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (03) :603-612
[7]  
CARBONE FR, 1994, CELL, V76, P17
[8]   The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J].
Carreno, BM ;
Collins, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :29-53
[9]   Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype [J].
Dengler, TJ ;
Pober, JS .
JOURNAL OF IMMUNOLOGY, 2000, 164 (10) :5146-5155
[10]   Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis [J].
Dong, HD ;
Strome, SE ;
Matteson, EL ;
Moder, KG ;
Flies, DB ;
Zhu, GF ;
Tamura, H ;
Driscoll, CLW ;
Chen, LP .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03) :363-370